US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,839.06

+18.751.03%

Number of Gainers:11

Number of Losers:7

Number of Flat:- -

PE:- -

High:1,844.35

Open:1,819.74

Low:1,815.03

Close:1,820.31

Volume:98.02M

Turnover:6.47B

Market Cap:1.50T

Float Cap:1.48T

Loading ...

Pfizer Invests Nearly $500 Million to Partner with Chinese Biotech Firm, Expanding Presence in China's Weight-Loss Drug Market

Analysts Offer Insights on Healthcare Companies: Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF) and Vir Biotechnology (VIR)

Sciwind Biosciences Partners with Pfizer China to Commercialize its Biased GLP-1 in China

Pfizer Acquires Exclusive Rights to Obesity Drug in China

Sciwind Biosciences and Pfizer China Forge Strategic Partnership for Ecnoglutide Commercialization

EQ Resources Completes Documents for Prepayment Facility Repayable via Set-Off Against Monthly Tungsten Oxide Concentrate Deliveries, Shares Fall 3%

MT Newswires Live

COLUMN-Novartis quietly settles Henrietta Lacks suit as family’s legal push gains steam

Hangzhou Sciwind Biosciences and Pfizer China Announce Strategic Cooperation Agreement on Commercialisation of New Generation of Ecnoglutide Injection

THOMSON REUTERS

EQ Resources Refinances Spanish Debt With €15m Traxys Prepayment Deal

Vir Biotechnology Inc reports results for the quarter ended September 30 - Earnings Summary

Stocks to Watch: Diamondback Energy, Hims & Hers, Vir Bio, Whirlpool

Law firm Gibson Dunn loses appeal over ex-partner's retirement pay

Vir Biotechnology Q4 Loss Narrows, Revenue Rises

MT Newswires Live

Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Vir Biotechnology Q4 revenue beats estimates

Johnson & Johnson EVP, WW Chair, MedTech Timothy Schmid Disposes of Common Shares

BRIEF-Vir Biotechnology Q4 EPS USD -0.31

Vir posts Q4 revenue of USD 64.1 million up 5.17x

Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4568/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1839.0577,"timestamp":1771880399999,"preClose":1820.3057,"halted":0,"volume":98023433,"delay":0,"changeRate":0.010302,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":18.752075,"latestTime":"02-23 16:00:00 EST","open":1819.7351,"high":1844.3469,"low":1815.031,"amount":6470786377.296041,"amplitude":0.016105,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771923600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.576431,"peRate":26.855529,"turnoverRate":0.007083,"increases":11,"decrements":7,"flats":0,"marketCap":1503745191758.25,"floatMarketCap":1479908328347.25},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1844.3469,"amplitude":0.016105,"preClose":1820.3057,"low":1815.031,"pbRate":"4.576431","latestPrice":1839.0577,"volume":98023433,"delay":0,"open":1819.7351,"prevYearClose":1637.1339,"prevWeekClose":1820.3057,"prevMonthClose":1721.4615,"prevQuarterClose":1637.1339,"fiveDayClose":1833.2484,"twentyDayClose":1685.1011,"sixtyDayClose":1637.046,"secType":"PLATE","market":"US","turnoverRate":0.007083,"peRate":26.855529,"marketCap":1503745191758.25,"floatMarketCap":1479908328347.25,"timestamp":1771880399999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":11,"down":7,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1155502746","title":"Pfizer Invests Nearly $500 Million to Partner with Chinese Biotech Firm, Expanding Presence in China's Weight-Loss Drug Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1155502746","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155502746?lang=en_us&edition=fundamental","pubTime":"2026-02-24 15:01","pubTimestamp":1771916502,"startTime":"0","endTime":"0","summary":"U.S. pharmaceutical giant Pfizer has entered into an agreement with domestic startup Hangzhou Sciwind Biosciences to secure exclusive commercialization rights in China for one of the latter’s...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456855351.SGD","BK4007","SG9999013999.USD","SG9999001176.USD","LU0058720904.USD","LU0170899867.USD","IE00BLSP4239.USD","IE0002270589.USD","LU0225284248.USD","BK4599","IE00B19Z3B42.SGD","IE00B19Z3581.USD","BK4588","LU0868494617.USD","LU1023059063.AUD","LU1057294990.SGD","BK4592","LU0289739699.SGD","LU1894683264.USD","LU1894683348.USD","LU0306807586.USD","IE000M9KFDE8.USD","PFE","LU0225771236.USD","BK4568","BK4581","IE00BBT3K403.USD","LU0122379950.USD","BK4533","SG9999001176.SGD","LU0985481810.HKD","LU0321505439.SGD","SG9999002224.SGD","SG9999002232.USD","IE00BLSP4452.SGD","SGXZ57979304.SGD","SG9999011175.SGD","BK4550","LU0321505868.SGD","LU0306806265.USD","LU1066053197.SGD","BK4534","SG9999003800.SGD","LU0234572021.USD","BK4585","LU1883839398.USD","LU1066051498.USD"],"gpt_icon":1},{"id":"2613762763","title":"Analysts Offer Insights on Healthcare Companies: Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF) and Vir Biotechnology (VIR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2613762763","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613762763?lang=en_us&edition=fundamental","pubTime":"2026-02-24 14:40","pubTimestamp":1771915226,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Fisher & Paykel Healthcare Corporation Limited (FSPK...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fisher-paykel-healthcare-corporation-limited-otherfspkf-and-vir-biotechnology-vir-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fisher-paykel-healthcare-corporation-limited-otherfspkf-and-vir-biotechnology-vir-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","XBI","FPH.NZ","BK4581","BK4139","BK4585","BK8004","BK4588","BK4568","BK4535","VIR","XLV"],"gpt_icon":0},{"id":"2613976915","title":"Sciwind Biosciences Partners with Pfizer China to Commercialize its Biased GLP-1 in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2613976915","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613976915?lang=en_us&edition=fundamental","pubTime":"2026-02-24 13:14","pubTimestamp":1771910040,"startTime":"0","endTime":"0","summary":"HANGZHOU, China, Feb. 24, 2026 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd.  today announced a strategic commercialization collaboration with Pfizer China for Ecnoglutide injection , a new–generation cAMP–biased GLP–1 receptor agonist. Under the agreement, Pfizer will obtain exclusive commercialization rights for the product in Mainland China, marking an important first step to advance Pfizer's global strategy in the metabolic field in China. Sciwind Biosciences will remain the Marketing Authorization Holder and will be responsible for research and development, registration, manufacturing, and supply of the product. Under the terms of the agreement, Sciwind Biosciences is eligible to receive up to $495M in upfront, regulatory and sales milestone payments.Alexandre de Germay, Chief International Commercial Officer, Executive Vice President of Pfizer, stated: \"This collaboration represents another solid step to advance Pfizer's global strategy in the metabolic field and reflect","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/sciwind-biosciences-partners-with-pfizer-china-to-commercialize-its-biased-glp-1-in-china-302695333.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU1023059063.AUD","LU0868494617.USD","BK4599","PFE","LU1066051498.USD","LU0321505868.SGD","IE00BBT3K403.USD","SG9999011175.SGD","LU0306807586.USD","BK4588","SG9999013999.USD","IE0002270589.USD","IE00B19Z3581.USD","LU0122379950.USD","SG9999001176.SGD","BK4533","BK4581","BK6502","LU0289739699.SGD","BK4592","BK4585","SG9999001176.USD","BK4590","IE00BLSP4239.USD","LU1894683264.USD","SG9999002224.SGD","IE000M9KFDE8.USD","LU1883839398.USD","BK4534","LU1057294990.SGD","SG9999003800.SGD","SGXZ57979304.SGD","LU0225284248.USD","LU0225771236.USD","LU0234572021.USD","LU1894683348.USD","BK4568","LU0170899867.USD","LU0306806265.USD","IE00BLSP4452.SGD","5OX.SI","IE00B19Z3B42.SGD","LU0058720904.USD","SG9999002232.USD","LU0321505439.SGD","LU0456855351.SGD","LU1066053197.SGD","BK4550","LU0985481810.HKD","BK4144","BK6097"],"gpt_icon":1},{"id":"2613776611","title":"Pfizer Acquires Exclusive Rights to Obesity Drug in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2613776611","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613776611?lang=en_us&edition=fundamental","pubTime":"2026-02-24 12:47","pubTimestamp":1771908420,"startTime":"0","endTime":"0","summary":"Pfizer has acquired exclusive rights to commercialize an obesity therapy in China in a deal worth up to $495 million.The U.S. drugmaker reached an agreement with Hangzhou Sciwind Biosciences for ecnoglutide, a drug recently approved by Chinese regulators to treat diabetes, according to a statement posted on WeChat on Tuesday. The therapy is also under regulatory review for obesity treatment, the statement said.The potential $495 million payment includes an upfront fee as well as regulatory and milestone payments, Sciwind said.The collaboration with Sciwind \"marks a significant milestone in accelerating Pfizer's long-term strategic footprint in the metabolic field,\" said Pfizer China president Jean-Christophe Pointeau in the statement.Chinese biotech companies are increasingly partnering with overseas drugmakers. Earlier this month, Innovent Biologics announced a collaboration with Eli Lilly that includes up to $8.5 billion in milestone payments.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999003800.SGD","LU0868494617.USD","BK4585","LU0122379950.USD","IE0002270589.USD","LU1066051498.USD","LU1066053197.SGD","SG9999001176.SGD","SG9999013999.USD","LU0321505439.SGD","LU0306806265.USD","LU1057294990.SGD","SG9999002232.USD","LU0225771236.USD","LU0321505868.SGD","SGXZ57979304.SGD","LU0456855351.SGD","LU0234572021.USD","LU1894683264.USD","IE00B19Z3581.USD","BK4599","IE000M9KFDE8.USD","LU0058720904.USD","LU1023059063.AUD","SG9999002224.SGD","IE00B19Z3B42.SGD","LU0985481810.HKD","BK4592","LU1894683348.USD","IE00BBT3K403.USD","SG9999011175.SGD","LU1883839398.USD","LU0170899867.USD","LU0289739699.SGD","IE00BLSP4239.USD","BK4533","BK4007","BK4534","BK4550","BK4588","LU0225284248.USD","LU0306807586.USD","SG9999001176.USD","IE00BLSP4452.SGD","BK4581","PFE","BK4568"],"gpt_icon":0},{"id":"1149060519","title":"Sciwind Biosciences and Pfizer China Forge Strategic Partnership for Ecnoglutide Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=1149060519","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149060519?lang=en_us&edition=fundamental","pubTime":"2026-02-24 10:34","pubTimestamp":1771900489,"startTime":"0","endTime":"0","summary":"Hangzhou Sciwind Biosciences Co., Ltd. and Pfizer China announced today that they have entered into a strategic commercialization agreement for the next-generation biased GLP-1 receptor agonist,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456855351.SGD","BK4007","SG9999013999.USD","SG9999001176.USD","LU0058720904.USD","LU0170899867.USD","IE00BLSP4239.USD","IE0002270589.USD","LU0225284248.USD","BK4599","IE00B19Z3B42.SGD","IE00B19Z3581.USD","91078","BK4588","LU0868494617.USD","LU1023059063.AUD","LU1057294990.SGD","BK4592","LU0289739699.SGD","LU1894683264.USD","LU1894683348.USD","LU0306807586.USD","IE000M9KFDE8.USD","PFE","LU0225771236.USD","BK4568","BK4581","IE00BBT3K403.USD","LU0122379950.USD","BK4533","SG9999001176.SGD","LU0985481810.HKD","LU0321505439.SGD","SG9999002224.SGD","SG9999002232.USD","IE00BLSP4452.SGD","SGXZ57979304.SGD","SG9999011175.SGD","BK4550","LU0321505868.SGD","LU0306806265.USD","LU1066053197.SGD","BK4534","SG9999003800.SGD","LU0234572021.USD","BK4585","LU1883839398.USD","LU1066051498.USD"],"gpt_icon":1},{"id":"2613757910","title":"EQ Resources Completes Documents for Prepayment Facility Repayable via Set-Off Against Monthly Tungsten Oxide Concentrate Deliveries, Shares Fall 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613757910","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613757910?lang=en_us&edition=fundamental","pubTime":"2026-02-24 10:10","pubTimestamp":1771899013,"startTime":"0","endTime":"0","summary":"EQ Resources  completed its transaction documents with Traxys Europe for a three-year 15 million euros prepayment facility repayable via set-off against monthly concentrate deliveries of tungsten oxide, while also entering into a five-year commercial agreement with Traxys, under which 3,500 tonnes of tungsten oxide produced from its Barruecopardo mine in Spain will be sold to Traxys at the prevailing spot price of delivery, according to a Tuesday Australian bourse filing.The value of the commercial agreement is around AU$678 million, based on current spot prices.The proceeds from the prepayment facility will be used to refinance 15 million euros of the existing debt facilities owed by the firm's wholly-owned subsidiary Salaro.Its shares fell 3% in recent trading on Tuesday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7095","EQR.AU","BK4139","EQ","BK4568"],"gpt_icon":0},{"id":"2613383752","title":"COLUMN-Novartis quietly settles Henrietta Lacks suit as family’s legal push gains steam","url":"https://stock-news.laohu8.com/highlight/detail?id=2613383752","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613383752?lang=en_us&edition=fundamental","pubTime":"2026-02-24 09:32","pubTimestamp":1771896727,"startTime":"0","endTime":"0","summary":"COLUMN-Novartis quietly settles Henrietta Lacks suit as family’s legal push gains steamThe opinions expressed here are those of the author, a columnist for Reuters.By Jenna Greene","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL1N3ZJ0ZI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2543165471.USD","LU1989771016.USD","LU2468319806.SGD","BK4139","BK4581","IE00B1BXHZ80.USD","IE0034235188.USD","LU0528227936.USD","LU1983299246.USD","LU1854104046.USD","LU0225284248.USD","IE00B19Z3581.USD","LU1291159041.SGD","LU1670628061.USD","LU2112291526.USD","BK4007","LU1923622614.USD","LU0306806265.USD","LU0640476718.USD","LU2720916845.USD","BK4533","LU2041044095.USD","LU2211814178.USD","LU2125909916.SGD","BK4568","LU2092937221.SGD","LU0957791311.USD","LU1923622291.USD","IE0002141913.USD","LU1720051108.HKD","LU1066051498.USD","LU1803068623.USD","LU0266013472.USD","LU0321505439.SGD","LU1883839398.USD","LU0342679015.USD","LU2087621335.USD","LU1670627923.USD","LU0320765489.SGD","IE0002270589.USD","IE00B19Z3B42.SGD","LU1280957306.USD","LU0170899867.USD","IE00B19Z8X17.USD","LU2433249047.HKD","LU2298321311.HKD","LU1894683264.USD","BK4592","LU0345770308.USD","SG9999011175.SGD","BK4121","LU1066053197.SGD","LU0225771236.USD","LU0070302665.USD","LU2125910336.SGD","BK4548","LU1923621640.USD","LU0289739699.SGD","LU2125909247.SGD","LU1791710400.SGD","LU0234572021.USD","SG9999003800.SGD","LU0011850046.USD","LU2764263203.CNY","BK4535","SG9999001176.USD","IE00BJJMRZ35.SGD","LU1988902786.USD","IE00BLSP4239.USD","SG9999002232.USD","IE00B2B36J28.USD","BK4585","LU2764262908.HKD","LU0985481810.HKD","LU1548497426.USD","LU0557290698.USD","BK4599","LU2360108059.USD","LU2125909593.SGD","LU1839511570.USD","LU2089984988.USD","LU1854103824.USD","BK4534","IE00BJT1NW94.SGD","LU1023059063.AUD","LU0345770993.USD","LU1633808545.USD","LU0316494557.USD","LU0114720955.EUR","LU0061474960.USD","LU0306807586.USD","LU1061106388.HKD","LU0882574055.USD","LU2764263039.SGD","BK4588","IE000M9KFDE8.USD","IE00B19Z8W00.USD","LU0868494617.USD","LU2125910179.SGD","IE00BKPKM429.USD","IE00BLSP4452.SGD","LU0208291251.USD","GB00BDT5M118.USD","LU1064131342.USD","LU0122379950.USD","SG9999002224.SGD","LU0823416689.USD","LU1720051017.SGD","LU1623119135.USD","SGXZ57979304.SGD","SG9999001176.SGD","LU1894683348.USD","IE00BBT3K403.USD","LU1712237335.SGD","IE00B19Z9505.USD","LU0096362180.USD","BK4566","NVS","IE0009355771.USD","LU0058720904.USD","IE00B4R5TH58.HKD","LU0456855351.SGD","LU1815333072.USD","LU1057294990.SGD","LU2063271972.USD","LU2357305700.SGD","LU2264538146.SGD","LU2125909759.SGD","BK4550","LU1791710582.SGD","SG9999013999.USD","BK4583","LU1153585028.USD","LU0321505868.SGD","IE00BFTCPJ56.SGD","LU2211815571.USD"],"gpt_icon":0},{"id":"2613754721","title":"Hangzhou Sciwind Biosciences and Pfizer China Announce Strategic Cooperation Agreement on Commercialisation of New Generation of Ecnoglutide Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2613754721","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613754721?lang=en_us&edition=fundamental","pubTime":"2026-02-24 09:28","pubTimestamp":1771896511,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nP8N3Y004S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1894683264.USD","LU0122379950.USD","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","LU0868494617.USD","BK4585","BK4568","LU0456855351.SGD","BK4550","IE00BLSP4239.USD","SG9999002224.SGD","BK4592","LU1883839398.USD","LU1023059063.AUD","LU1066051498.USD","LU1894683348.USD","BK4534","LU0321505439.SGD","IE00BLSP4452.SGD","02252","LU0985481810.HKD","LU0289739699.SGD","BK4533","LU0321505868.SGD","LU0234572021.USD","SG9999001176.USD","SG9999001176.SGD","LU0058720904.USD","BK4007","BK4581","LU0170899867.USD","LU1057294990.SGD","SG9999002232.USD","LU0306806265.USD","IE0002270589.USD","PFE","BK4599","SG9999013999.USD","BK4588","IE00BBT3K403.USD","LU1066053197.SGD","LU0225771236.USD","SG9999011175.SGD","LU0306807586.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","SG9999003800.SGD","LU0225284248.USD"],"gpt_icon":0},{"id":"2613596797","title":"EQ Resources Refinances Spanish Debt With €15m Traxys Prepayment Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2613596797","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613596797?lang=en_us&edition=fundamental","pubTime":"2026-02-24 08:08","pubTimestamp":1771891703,"startTime":"0","endTime":"0","summary":"EQ Resources Limited ( ($AU:EQR) ) has issued an announcement. EQ Resources has arranged a three-year €15 million prepayment facility with commodit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eq-resources-refinances-spanish-debt-with-e15m-traxys-prepayment-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eq-resources-refinances-spanish-debt-with-e15m-traxys-prepayment-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","EQ","BK4568"],"gpt_icon":0},{"id":"2613565227","title":"Vir Biotechnology Inc reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2613565227","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613565227?lang=en_us&edition=fundamental","pubTime":"2026-02-24 07:44","pubTimestamp":1771890246,"startTime":"0","endTime":"0","summary":"Vir Biotechnology Inc reports results for the quarter ended September 30 - Earnings SummaryVir Biotechnology Inc VIR.OQ reported a quarterly adjusted loss of 31 cents per share for the quarter ended S","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nL8N3ZJ2KR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4585","BK4535","VIR","BK4139"],"gpt_icon":0},{"id":"2613763304","title":"Stocks to Watch: Diamondback Energy, Hims & Hers, Vir Bio, Whirlpool","url":"https://stock-news.laohu8.com/highlight/detail?id=2613763304","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613763304?lang=en_us&edition=fundamental","pubTime":"2026-02-24 07:40","pubTimestamp":1771890000,"startTime":"0","endTime":"0","summary":"Diamondback Energy posted a loss as falling oil prices dented the value of its acquisitions in 2025. Shares fell 3% to $169.50 in after-hours trading Monday.Hims & Hers Health guided for lower-than-expected revenue in the first quarter. The stock declined 6.6% to $14.48 after the bell.Vir Biotechnology signed a $335 million licensing deal for its prostate cancer treatment. Shares gained 62% to $12.07.Whirlpool initiated public offerings to help chip away at its debt and investments in automation. The stock slipped 7.5% to $76.97.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIYY","BK4535","BK4139","HIMS","BK4213","LU0251131958.USD","BK4568","HIMZ","BK4588","HIMY","IE00B2Q91V27.USD","BK4585","LU0048573561.USD","LU0251142724.SGD","LU0742534661.SGD","WHR","FANG","BK4196","VIR","IE00B3CCJ963.GBP","BK4191","IE00BGHQF524.EUR","HMYY"],"gpt_icon":1},{"id":"2613980755","title":"Law firm Gibson Dunn loses appeal over ex-partner's retirement pay","url":"https://stock-news.laohu8.com/highlight/detail?id=2613980755","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613980755?lang=en_us&edition=fundamental","pubTime":"2026-02-24 07:08","pubTimestamp":1771888134,"startTime":"0","endTime":"0","summary":"Law firm Gibson Dunn loses appeal over ex-partner's retirement payBy Mike Scarcella. Gibson Dunn loses ruling in pay fight with $60 million ex-partner","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nL6N3ZJ10O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU0648001328.SGD","LU0985481810.HKD","LU1059921491.USD","LU1244550221.USD","LU0289739699.SGD","LU0225284248.USD","IE00B894F039.SGD","BK4115","LU1150488135.SGD","LU0321505868.SGD","LU1066053197.SGD","SG9999013999.USD","LU1023059063.AUD","LU0708994859.HKD","IE000M9KFDE8.USD","SG9999011175.SGD","LU0225771236.USD","LU0985489474.SGD","LU1267930573.SGD","BK4100","LU0321505439.SGD","IE00B19Z9Z06.USD","LU0058720904.USD","LU0068578508.USD","LU1074936037.SGD","BK4550","LU0310800379.SGD","IE00BBT3K403.USD","LU0122379950.USD","LU0980610538.SGD","BK4534","LU0029864427.USD","BK4533","LU1150488218.USD","LU0070302665.USD","LU1057294990.SGD","LU1244550494.USD","BK4007","IE00BSNM7G36.USD","LU1894683348.USD","SG9999002232.USD","BK4566","IE00BLSP4452.SGD","LU0433182093.SGD","SG9999001176.SGD","LU1883839398.USD","BK4599","IE00B19Z3B42.SGD","BK4598","SG9999002224.SGD","BK4588","LU0456855351.SGD","LU0878866978.SGD","LU1894683264.USD","LU0320765489.SGD","LU0942090050.USD","IE00BLSP4239.USD","BK4568","BK4507","LU0208291251.USD","CMCSA","LU0868494708.USD","SGXZ57979304.SGD","LU0234572021.USD","IE00B19Z3581.USD","LU1244550577.SGD","IE0002270589.USD","LU0306806265.USD","LU0868494617.USD","SG9999001176.USD","BK4585","SG9999003800.SGD","LU0306807586.USD","IE00B19Z9P08.USD","LU1066051498.USD","LU0170899867.USD","BK4592","LU0130102774.USD","LU0128525929.USD","LU1489326972.SGD","LU1201861249.SGD"],"gpt_icon":1},{"id":"2613153753","title":"Vir Biotechnology Q4 Loss Narrows, Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2613153753","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613153753?lang=en_us&edition=fundamental","pubTime":"2026-02-24 06:31","pubTimestamp":1771885866,"startTime":"0","endTime":"0","summary":"Vir Biotechnology (VIR) reported a Q4 net loss late Monday of $0.31 per diluted share, narrowing from a loss of $0.76 a year earlier.Revenue for the quarter ended Dec. 31 was $64.1 million, up from $12.4 million a year earlier.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4568","BK4535","BK4585","BK4139","VIR"],"gpt_icon":0},{"id":"2613633987","title":"Novavax Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2613633987","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613633987?lang=en_us&edition=fundamental","pubTime":"2026-02-24 06:29","pubTimestamp":1771885740,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Novavax Inc.  rose 1.74% to $9.36 Monday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index  falling 1.13% to 22,627.27 and Dow Jones Industrial Average  falling 1.66% to 48,804.06.Novavax Inc. closed 12.07% below its 52-week high of $10.64, which the company reached on August 18th.The stock outperformed some of its competitors Monday, as Johnson & Johnson  rose 1.38% to $245.84, Pfizer Inc.  rose 1.54% to $27.06, and Merck & Co. Inc.  rose 1.28% to $123.82.Trading volume  remained 4.6 million below its 50-day average volume of 4.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled February 23, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001176.USD","IE00BN8TJ469.HKD","SG9999014575.USD","IE00BLSP4452.SGD","LU0006306889.USD","LU1571399168.USD","IE00B3T34201.USD","LU2129689514.USD","LU0070302665.USD","BK4581","LU0882574055.USD","LU1093756325.SGD","LU1066051811.HKD","LU2505996681.GBP","LU1066051498.USD","LU1023059063.AUD","LU0985481810.HKD","LU2361044949.HKD","LU0985320562.USD","LU0203347892.USD","LU2461242641.AUD","LU1035773651.USD","LU1221951129.SGD","NVAX","SG9999013999.USD","LU1032955483.USD","LU1778281490.HKD","LU1116320901.HKD","LU2125154778.USD","SG9999011175.SGD","SG9999003800.SGD","LU0320765646.SGD","BK4588","LU1674673428.USD","LU2129689431.USD","IE0009355771.USD","IE00B1BXHZ80.USD","LU1244550494.USD","IE00B2B36J28.USD","LU2471134796.USD","LU1069347547.HKD","LU2361045086.USD","LU1506573853.SGD","LU0106261372.USD","LU0238689110.USD","LU0124676726.USD","LU1201861249.SGD","BK4007","LU1291159041.SGD","LU2468319806.SGD","LU1699723380.USD","LU1929549753.HKD","LU1037948541.HKD","IE00B19Z3B42.SGD","BK4532","IE00B19Z3581.USD","LU1974910355.USD","IE00BLSP4239.USD","LU2133065610.SGD","LU0070217475.USD","LU0795875169.SGD","LU0345769631.USD","IE00BBT3K403.USD","LU1066053197.SGD","LU2505996509.AUD","LU2023250843.SGD","IE00BFTCPJ56.SGD","LU0122379950.USD","LU2089984988.USD","LU2471134952.CNY","LU0345769128.USD","LU1718418525.SGD","LU0321505868.SGD","LU1934455194.USD","LU2361044865.SGD","LU1066051225.USD","LU1732799900.SGD","LU1093756168.USD","LU2112291526.USD","LU1221951046.USD","BK4559","LU1280957306.USD","LU0477156953.USD","SG9999001440.SGD","IE00BZ1G4Q59.USD","LU1061106388.HKD","BK4139","IE00B4R5TH58.HKD","LU0683600562.USD","BK4592","BK4550","LU1032466523.USD","LU1057294990.SGD","IE00BFXG1179.USD","LU1261432733.SGD","LU1496350502.SGD","LU0234570918.USD","LU0965509283.SGD","LU2602419157.SGD","LU2750360641.GBP","LU1244550577.SGD","LU0965508806.USD","LU1430594728.SGD","LU1883839398.USD","IE000M9KFDE8.USD","IE00BVYPNW00.USD","LU0320765489.SGD","LU1917777945.USD","LU0265550359.USD","LU1941712264.USD","LU2471134523.USD","LU2324357040.USD","IE00B7SZLL34.SGD","IE00BSNM7G36.USD","LU0098860793.USD","LU1674673691.USD","LU1983299246.USD","LU0456855351.SGD","SG9999015341.SGD","SG9999001176.SGD","LU0289739699.SGD","LU0345770308.USD","LU0466842654.USD","LU0648001328.SGD","LU1894683348.USD","LU0306807586.USD","IE00BJJMRZ35.SGD","LU0058720904.USD","LU0114720955.EUR","LU1116320737.USD","LU2430703251.USD","LU2750360997.AUD","LU2360032135.SGD","LU0170899867.USD","LU2106854487.HKD","LU2125154935.USD","SG9999002224.SGD","LU1059921491.USD","LU2347655156.SGD","LU2592432038.USD","LU0321505439.SGD","LU0225771236.USD","IE00BDGV0183.EUR","LU2129689605.HKD","LU0265550946.USD","LU2471134879.HKD","SG9999014542.SGD","LU1935042991.SGD","LU1934455277.USD","LU1244550221.USD","LU0965509101.SGD","IE0001KFT4U8.USD","LU0234572021.USD","LU0306806265.USD","LU1989772840.SGD","LU0689626769.HKD","LU0912757837.SGD","LU0432979614.USD","BK4585","LU1989772923.USD","LU0345770993.USD","LU0640476718.USD","IE00B42XCP33.USD","LU0868494617.USD","SG9999002232.USD","IE00BVYPNV92.GBP","LU2430703178.SGD","IE00BGHQF631.EUR","LU1267930813.SGD","LU0889566641.SGD","LU1894683264.USD","LU0208291251.USD","BK4533","IE00BJT1NW94.SGD","LU1074936037.SGD","LU0266013472.USD","LU1196500208.SGD","LU1037948897.HKD","BK4599","LU0130517989.USD","LU1585245621.USD","IE00B3PB1722.GBP","LU1941712348.USD","BK4504","SG9999014559.SGD","LU1914381329.SGD","BK4547","LU0130102774.USD","LU0225284248.USD","LU0787776722.HKD","LU0795875086.SGD","BK4516","BK4568","LU1989771016.USD","LU0211331839.USD","LU2023250504.SGD","LU1162221912.USD","IE0002141913.USD","LU0203345920.USD","LU0965509010.AUD","LU0980610538.SGD","IE0034235303.USD","LU0792757196.USD","LU0861579265.USD","IE00BKVL7J92.USD","BK4534","LU1934455863.HKD","IE0002270589.USD","SG9999014567.USD","LU2430703095.HKD","SG9999015358.SGD","SGXZ57979304.SGD","LU1732800096.USD"],"gpt_icon":0},{"id":"2613633627","title":"Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2613633627","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613633627?lang=en_us&edition=fundamental","pubTime":"2026-02-24 06:26","pubTimestamp":1771885560,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Inovio Pharmaceuticals Inc.  rallied 4.62% to $1.81 Monday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 1.13% to 22,627.27 and Dow Jones Industrial Average  falling 1.66% to 48,804.06.This was the stock's sixth consecutive day of gains.Inovio Pharmaceuticals Inc. closed 39.24% short of its 52-week high of $2.98, which the company achieved on September 9th.The stock outperformed some of its competitors Monday, as Johnson & Johnson  rose 1.38% to $245.84, Statera Biopharma Inc.  fell 50.00% to $0.00, and Pfizer Inc.  rose 1.54% to $27.06.Trading volume  remained 1.5 million below its 50-day average volume of 1.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled February 23, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1732799900.SGD","LU2468319806.SGD","LU0124676726.USD","LU2750360641.GBP","BK4139","BK4581","IE00B1BXHZ80.USD","IE00BN8TJ469.HKD","IE00B3PB1722.GBP","LU0345769631.USD","LU1983299246.USD","LU0225284248.USD","IE00B19Z3581.USD","LU2505996681.GBP","LU0203345920.USD","LU2112291526.USD","BK4007","LU1221951046.USD","LU0795875086.SGD","IE00B3T34201.USD","LU0306806265.USD","LU0640476718.USD","BK4533","LU1221951129.SGD","LU1929549753.HKD","BK4568","LU0795875169.SGD","LU1430594728.SGD","IE00BVYPNV92.GBP","LU2471134523.USD","IE0002141913.USD","LU1066051498.USD","LU2430703178.SGD","LU0321505439.SGD","LU1883839398.USD","IE00BZ1G4Q59.USD","LU2129689605.HKD","LU2602419157.SGD","LU1506573853.SGD","IE0002270589.USD","IE00B19Z3B42.SGD","LU0234570918.USD","LU1280957306.USD","LU0170899867.USD","LU0070217475.USD","LU1066051225.USD","LU1894683264.USD","BK4592","LU0203347892.USD","LU1261432733.SGD","INO","LU0345770308.USD","LU1732800096.USD","LU2592432038.USD","SG9999011175.SGD","LU1059921491.USD","LU1066053197.SGD","LU0225771236.USD","BK4532","IE0034235303.USD","LU0289739699.SGD","LU0912757837.SGD","LU2347655156.SGD","LU0234572021.USD","IE0001KFT4U8.USD","LU0345769128.USD","SG9999003800.SGD","IE00BFXG1179.USD","LU1674673691.USD","LU1244550577.SGD","SG9999001176.USD","IE00BJJMRZ35.SGD","IE00BLSP4239.USD","SG9999002232.USD","IE00B2B36J28.USD","BK4585","LU2471134952.CNY","LU0985481810.HKD","LU2471134879.HKD","LU2133065610.SGD","LU1196500208.SGD","BK4599","LU1162221912.USD","IE00B7SZLL34.SGD","LU2089984988.USD","LU1032466523.USD","LU2129689431.USD","IE00BDGV0183.EUR","LU1935042991.SGD","LU1267930813.SGD","BK4534","IE00BJT1NW94.SGD","LU1023059063.AUD","LU0345770993.USD","LU0889566641.SGD","LU0114720955.EUR","IE00BKVL7J92.USD","LU0306807586.USD","LU1061106388.HKD","LU0689626769.HKD","LU0882574055.USD","LU2430703095.HKD","LU1718418525.SGD","BK4588","LU0985320562.USD","IE000M9KFDE8.USD","LU0868494617.USD","LU1674673428.USD","LU1244550494.USD","LU1032955483.USD","IE00BLSP4452.SGD","BK4559","LU0122379950.USD","SG9999002224.SGD","LU0683600562.USD","LU0320765646.SGD","SG9999001440.SGD","SGXZ57979304.SGD","LU2471134796.USD","SG9999001176.SGD","LU0792757196.USD","LU2430703251.USD","LU1066051811.HKD","IE00BBT3K403.USD","LU1894683348.USD","LU1778281490.HKD","IE00BVYPNW00.USD","LU0787776722.HKD","LU1244550221.USD","LU0466842654.USD","LU1914381329.SGD","IE0009355771.USD","LU2129689514.USD","LU0058720904.USD","IE00B4R5TH58.HKD","LU0098860793.USD","LU0456855351.SGD","LU2750360997.AUD","IE00BSNM7G36.USD","LU1057294990.SGD","LU2505996509.AUD","LU1496350502.SGD","LU1585245621.USD","BK4504","BK4550","SG9999013999.USD","BK4583","LU0321505868.SGD","LU1074936037.SGD","IE00BFTCPJ56.SGD","IE00BGHQF631.EUR","IE00B42XCP33.USD","LU0432979614.USD"],"gpt_icon":0},{"id":"2613753694","title":"Vir Biotechnology Q4 revenue beats estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2613753694","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613753694?lang=en_us&edition=fundamental","pubTime":"2026-02-24 06:23","pubTimestamp":1771885387,"startTime":"0","endTime":"0","summary":"Vir Biotechnology Q4 revenue beats estimatesOverviewBiopharmaceutical firm's Q4 revenue beat analyst expectations, driven by Norgine license revenueCompany reported a net loss for Q4, decreased compar","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nL1N3ZJ159:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","VIR","BK4585","BK4568","BK4139"],"gpt_icon":0},{"id":"2613656753","title":"Johnson & Johnson EVP, WW Chair, MedTech Timothy Schmid Disposes of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2613656753","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613656753?lang=en_us&edition=fundamental","pubTime":"2026-02-24 06:21","pubTimestamp":1771885262,"startTime":"0","endTime":"0","summary":"Timothy Schmid, EVP, WW Chair, MedTech at Johnson and Johnson, reported a disposal of common shares of Johnson and Johnson. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 23, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDL3vWz8w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Johnson & Johnson EVP, WW Chair, MedTech Timothy Schmid Disposes of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1506573853.SGD","BK4559","BK4533","LU0203345920.USD","LU1674673691.USD","BK4504","IE00B2B36J28.USD","BK4550","LU1244550577.SGD","LU1066053197.SGD","LU2430703095.HKD","IE00B1BXHZ80.USD","LU2471134952.CNY","LU1032466523.USD","IE00BLSP4239.USD","LU0345770993.USD","LU1023059063.AUD","BK4534","LU1221951046.USD","IE00B42XCP33.USD","LU1074936037.SGD","LU1244550221.USD","LU1935042991.SGD","LU1732799900.SGD","IE00BBT3K403.USD","IE00BSNM7G36.USD","LU1244550494.USD","JNJ","BK4007","LU2505996681.GBP","LU2471134879.HKD","LU0795875169.SGD","LU1196500208.SGD","LU0234572021.USD","LU1066051498.USD","BK4592","BK4568","LU0640476718.USD","LU2505996509.AUD","IE00BDGV0183.EUR","IE00BGHQF631.EUR","LU1066051811.HKD","IE00BFXG1179.USD","LU2602419157.SGD","LU2129689514.USD","LU0683600562.USD","LU1674673428.USD","IE00B19Z3B42.SGD","LU2129689431.USD","IE0002270589.USD"],"gpt_icon":0},{"id":"2613753820","title":"BRIEF-Vir Biotechnology Q4 EPS USD -0.31","url":"https://stock-news.laohu8.com/highlight/detail?id=2613753820","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613753820?lang=en_us&edition=fundamental","pubTime":"2026-02-24 06:14","pubTimestamp":1771884885,"startTime":"0","endTime":"0","summary":"BRIEF-Vir Biotechnology Q4 EPS USD -0.31\n\n\nFeb 23 (Reuters) - Vir Biotechnology Q4 revenue USD 64.1 million vs. IBES estimate USD 23.2 million.\n\nQ4 net income USD -42.9 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nPLX41D8E8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","VIR","BK4568","BK4535"],"gpt_icon":0},{"id":"2613753870","title":"Vir posts Q4 revenue of USD 64.1 million up 5.17x","url":"https://stock-news.laohu8.com/highlight/detail?id=2613753870","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613753870?lang=en_us&edition=fundamental","pubTime":"2026-02-24 06:14","pubTimestamp":1771884875,"startTime":"0","endTime":"0","summary":"Vir posts Q4 revenue of USD 64.1 million up 5.17x               Vir reported Q4 2025 revenue of USD 64.1 million and a net loss attributable to shareholders of USD 42.9 million (USD 0.31 per share). R","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDLc9tGhz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","VIR","BK4568","BK4535"],"gpt_icon":0},{"id":"2613758076","title":"Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2613758076","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613758076?lang=en_us&edition=fundamental","pubTime":"2026-02-24 06:14","pubTimestamp":1771884840,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nTUA35VRNJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4535","BK4568","VIR","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":1,"totalSize":409,"code":"91000000","status":"200"}]}}